​FTC and seven states seek contempt ruling against Shkreli over pharma ban

The FTC and seven states have sought a contempt ruling against Martin Shkreli for violating a lifetime ban on participating in the pharmaceutical industry.

Shkreli, known for raising the price of a life-saving drug, was released from prison in 2022 with conditions barring him from the industry.